{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:12:49Z","timestamp":1792383169073,"version":"4.4.0"},"reference-count":130,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Bone turnover abnormalities are common in chronic kidney disease (CKD) and contribute to bone fragility. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) introduced the term CKD-associated osteoporosis to describe bone fragility in CKD and highlighted the role of bone turnover markers (BTM) in clinical evaluation and management of bone fragility. However, current clinical practice guidelines lack specific treatment targets for bone turnover in the setting of CKD. The aim of this consensus was to present recommendations for the use of BTM in the management of CKD-associated osteoporosis. The consensus was conducted by members of relevant working groups of the European Renal Association (ERA), International Osteoporosis Foundation (IOF), European Foundation for Clinical Chemistry and Laboratory Medicine (EFLM) and European Society of Pediatric Nephrology (ESPN). Bone-specific alkaline phosphatase and tartrate resistant acid phosphatase isoform 5b are not renally cleared and considered reliable diagnostic tools for bone evaluation in CKD-associated osteoporosis. Both have been proposed as reference BTM in CKD by a recent international consortium. Intact N-terminal telopeptide of type I collagen can also be used in CKD. The current consensus describes methodological considerations and the clinical usefulness of BTM in risk prediction, choice of therapeutic strategy, and treatment evaluation in CKD-associated osteoporosis. Specific diagnostic ranges for bone turnover abnormalities are provided. Future research should focus on the integration of these reference BTM with other diagnostic tools, establishment of concrete treatment targets, and development of treatment strategies to reach these targets.<\/jats:p>","DOI":"10.1093\/ndt\/gfag033","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:25:16Z","timestamp":1771331116000},"page":"1357-1375","source":"Crossref","is-referenced-by-count":11,"title":["Bone turnover markers in the management of CKD-associated osteoporosis\u2014a European consensus"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8274-6356","authenticated-orcid":false,"given":"Mathias","family":"Haarhaus","sequence":"first","affiliation":[{"name":"Intervention and Technology, Karolinska Institutet, Karolinska Universitetssjukhuset Division of Renal Medicine, Department of Clinical Science, , Stockholm ,","place":["Sweden"]},{"name":"Diaverum AB , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0881-2615","authenticated-orcid":false,"given":"Hanne Skou","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital Department of Renal Medicine, , Aarhus ,","place":["Denmark"]},{"name":"Aarhus University Department of Clinical Medicine, , Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0578-2529","authenticated-orcid":false,"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[{"name":"Reference Center for Rare Diseases of Calcium and Phosphate, INSERM1033 Research Unit, Universit\u00e9 Lyon , Lyon ,","place":["France"]},{"name":"Hospices Civils de Lyon Department of Pediatric Nephrology, , Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anibal","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Nova Medical School , Lisbon ,","place":["Portugal"]},{"name":"Hospital Curry Cabral Department of Nephrology, , Lisbon ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1372-4417","authenticated-orcid":false,"given":"Serge","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Geneva University Hospital , Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9478-4851","authenticated-orcid":false,"given":"Maria","family":"Fusaro","sequence":"additional","affiliation":[{"name":"National Research Council, Institute of Clinical Physiology , Pisa ,","place":["Italy"]},{"name":"University of Padua Department of Medicine, , Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-7901","authenticated-orcid":false,"given":"Ditte","family":"Hansen","sequence":"additional","affiliation":[{"name":"University of Copenhagen Department of Clinical Medicine, , Copenhagen ,","place":["Denmark"]},{"name":"Copenhagen University Hospital \u2013 Herlev Department of Nephrology, , Herlev ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ketteler","sequence":"additional","affiliation":[{"name":"Robert-Bosch-Hospital Department of General Internal Medicine and Nephrology, , Stuttgart ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Lafage-Proust","sequence":"additional","affiliation":[{"name":"INSERM U1059 SAINBIOSE Universit\u00e9 Jean Monnet , Mines Saint-Etienne, Saint-Etienne ,","place":["France"]},{"name":"CHU Department of Rheumatology, , Saint-Priest-en-Jarez ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5387-3743","authenticated-orcid":false,"given":"Alexander D","family":"Lalayiannis","sequence":"additional","affiliation":[{"name":"Birmingham Women\u2019s and Children\u2019s NHS Foundation Trust Department of Pediatric Nephrology, , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2123-7838","authenticated-orcid":false,"given":"Per","family":"Magnusson","sequence":"additional","affiliation":[{"name":"Link\u00f6ping University Department of Clinical Chemistry, and Department of Biomedical and Clinical Sciences, , Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3071-1893","authenticated-orcid":false,"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[{"name":"Sapienza University of Rome Department of Translation and Precision Medicine, , Roma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9236-3906","authenticated-orcid":false,"given":"Syazrah","family":"Salam","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield , Sheffield ,","place":["UK"]},{"name":"Metabolic Bone Centre and Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-1072","authenticated-orcid":false,"given":"Rukshana","family":"Shroff","sequence":"additional","affiliation":[{"name":"University College London, Institute of Child Health , London ,","place":["UK"]},{"name":"UCL Great Ormond Street Hospital for Children NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[{"name":"University of Li\u00e8ge Department of Clinical Chemistry, CIRM, , CHU de Li\u00e8ge , Liege ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-3366","authenticated-orcid":false,"given":"Richard","family":"Eastell","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield , Sheffield ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-4321","authenticated-orcid":false,"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[{"name":"Nephrology and Renal Transplantation Research Group Department of Microbiology, Immunology and Transplantation, , Katholieke Universiteit Leuven, Leuven ,","place":["Belgium"]},{"name":"University Hospitals Leuven Department of Medicine, Division of Nephrology, , Leuven ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2026062922474327600_bib1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1681\/ASN.2010121253","article-title":"Differences in bone quality in low- and high-turnover renal osteodystrophy","volume":"23","author":"Malluche","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2026062922474327600_bib2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000369039","article-title":"Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysis","volume":"40","author":"Mathew","year":"2014","journal-title":"Am J Nephrol"},{"key":"2026062922474327600_bib3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","article-title":"Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"107","author":"Ketteler","year":"2025","journal-title":"Kidney International"},{"key":"2026062922474327600_bib4","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s00198-025-07422-3","article-title":"Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)","volume":"63(12)","author":"Bhattoa","year":"2025","journal-title":"Osteoporos Int"},{"key":"2026062922474327600_bib5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.7326\/M17-2640","article-title":"Diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder: synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update","volume":"168","author":"Ketteler","year":"2018","journal-title":"Ann Intern Med"},{"key":"2026062922474327600_bib6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1515\/cclm-2024-1148","article-title":"Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism","volume":"63","author":"Lombardi","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"2026062922474327600_bib7","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/clinchem\/45.7.1009","article-title":"Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women","volume":"45","author":"Kress","year":"1999","journal-title":"Clin Chem"},{"key":"2026062922474327600_bib8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0009-9120(96)00134-8","article-title":"The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects","volume":"30","author":"T\u00e4htel\u00e4","year":"1997","journal-title":"Clinical Biochemistry"},{"key":"2026062922474327600_bib9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1042\/bj3430063","article-title":"Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases","volume":"343","author":"Ljusberg","year":"1999","journal-title":"Biochem J"},{"key":"2026062922474327600_bib10","doi-asserted-by":"publisher","first-page":"28370","DOI":"10.1074\/jbc.M502469200","article-title":"Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts","volume":"280","author":"Ljusberg","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"2026062922474327600_bib11","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s40519-019-00776-8","article-title":"Intensive weight gain therapy in patients with anorexia nervosa results in improved serum tartrate-resistant acid phosphatase (TRAP) 5a and 5b isoform protein levels","volume":"25","author":"Patlaka","year":"2020","journal-title":"Eat Weight Disord"},{"key":"2026062922474327600_bib12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S0272-6386(03)00203-8","article-title":"Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis","volume":"41","author":"Chu","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"key":"2026062922474327600_bib13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00223-021-00930-4","article-title":"Practical considerations for the clinical application of bone turnover markers in osteoporosis","volume":"112","author":"Vasikaran","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"2026062922474327600_bib14","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.clinbiochem.2012.03.023","article-title":"Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum","volume":"45","author":"Koivula","year":"2012","journal-title":"Clinical Biochemistry"},{"key":"2026062922474327600_bib15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cca.2013.07.016","article-title":"Aminoterminal propeptide of type I procollagen (PINP) in chronic kidney disease patients: the assay matters","volume":"425","author":"Cavalier","year":"2013","journal-title":"Clinica Chimica Acta"},{"key":"2026062922474327600_bib16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cca.2019.11.012","article-title":"Bone alkaline phosphatase: an important biomarker in chronic kidney disease\u2013mineral and bone disorder","volume":"501","author":"Nizet","year":"2020","journal-title":"Clinica Chimica Acta"},{"key":"2026062922474327600_bib17","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1515\/cclm-2019-0174","article-title":"A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism","volume":"57","author":"Cavalier","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"2026062922474327600_bib18","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/nu14102124","article-title":"Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease","volume":"14","author":"Haarhaus","year":"2022","journal-title":"Nutrients"},{"key":"2026062922474327600_bib19","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00198-017-4082-4","article-title":"Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability","volume":"28","author":"Szulc","year":"2017","journal-title":"Osteoporos Int"},{"key":"2026062922474327600_bib20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000067254","article-title":"Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop","volume":"23","author":"Magnusson","year":"2002","journal-title":"Tumor Biol"},{"key":"2026062922474327600_bib21","doi-asserted-by":"publisher","first-page":"ziae006","DOI":"10.1093\/jbmrpl\/ziae006","article-title":"Glycoproteomic profile of human tissue-nonspecific alkaline phosphatase expressed in osteoblasts","volume":"8","author":"Atanasova","year":"2024","journal-title":"JBMR Plus"},{"key":"2026062922474327600_bib22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/clinchem\/40.5.822","article-title":"Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum","volume":"40","author":"Panigrahi","year":"1994","journal-title":"Clin Chem"},{"key":"2026062922474327600_bib23","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/clinchem\/44.10.2139","article-title":"Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase","volume":"44","author":"Broyles","year":"1998","journal-title":"Clin Chem"},{"key":"2026062922474327600_bib24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00223-001-1137-4","article-title":"Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization","volume":"71","author":"Magnusson","year":"2002","journal-title":"Calcified Tissue International"},{"key":"2026062922474327600_bib25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1523-1755.2001.00794.x","article-title":"Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms","volume":"60","author":"Magnusson","year":"2001","journal-title":"Kidney International"},{"key":"2026062922474327600_bib26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0378-4347(92)80177-R","article-title":"Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection","volume":"576","author":"Magnusson","year":"1992","journal-title":"Journal of Chromatography B: Biomedical Sciences and Applications"},{"key":"2026062922474327600_bib27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ki.2010.356","article-title":"Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease","volume":"79","author":"Damera","year":"2011","journal-title":"Kidney International"},{"key":"2026062922474327600_bib28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2215\/CJN.12031111","article-title":"Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality","volume":"8","author":"Filipowicz","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026062922474327600_bib29","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.clinbiochem.2010.09.019","article-title":"Validation of an automated intact N-terminal propeptide of type I procollagen (PINP) assay","volume":"43","author":"Koivula","year":"2010","journal-title":"Clinical Biochemistry"},{"key":"2026062922474327600_bib30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00198-020-05310-6","article-title":"Harmonization of commercial assays for PINP; the way forward","volume":"31","author":"Vasikaran","year":"2020","journal-title":"Osteoporos Int"},{"key":"2026062922474327600_bib31","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00198-017-4026-z","article-title":"Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population","volume":"28","author":"J\u00f8rgensen","year":"2017","journal-title":"Osteoporos Int"},{"key":"2026062922474327600_bib32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1572-0241.2006.01036.x","article-title":"An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease","volume":"102","author":"Koivisto","year":"2007","journal-title":"Am J Gastroenterology"},{"key":"2026062922474327600_bib33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/00365519950185120","article-title":"Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis","volume":"59","author":"Schytte","year":"1999","journal-title":"Scand J Clin Lab Invest"},{"key":"2026062922474327600_bib34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1515\/cclm-2021-1190","article-title":"Analytical evaluation of the Nittobo Medical tartrate resistant acid phosphatase isoform 5b (TRACP-5b) EIA and comparison with IDS iSYS in different clinically defined populations","volume":"60","author":"Cavalier","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2026062922474327600_bib35","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.clinbiochem.2014.04.007","article-title":"Inter-method variability in bone alkaline phosphatase measurement: clinical impact on the management of dialysis patients","volume":"47","author":"Cavalier","year":"2014","journal-title":"Clinical Biochemistry"},{"key":"2026062922474327600_bib36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cca.2020.12.023","article-title":"Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and beta-CTX in blood","volume":"515","author":"Bhattoa","year":"2021","journal-title":"Clinica Chimica Acta"},{"key":"2026062922474327600_bib37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.kint.2023.09.033","article-title":"Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease","volume":"105","author":"Cavalier","year":"2024","journal-title":"Kidney International"},{"key":"2026062922474327600_bib38","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1210\/jc.2015-2957","article-title":"Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women?","volume":"100","author":"Chavassieux","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062922474327600_bib39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1359\/jbmr.1997.12.1.59","article-title":"Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis","volume":"12","author":"Dr.\u00a0Eastell","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2026062922474327600_bib40","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1681\/ASN.2017050584","article-title":"Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy","volume":"29","author":"Salam","year":"2018","journal-title":"JASN"},{"key":"2026062922474327600_bib41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","article-title":"Diagnostic accuracy of noninvasive bone turnover markers in renal osteodystrophy","volume":"79","author":"J\u00f8rgensen","year":"2022","journal-title":"American Journal of Kidney Diseases"},{"key":"2026062922474327600_bib42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.ajkd.2015.02.323","article-title":"Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study","volume":"66","author":"Haarhaus","year":"2015","journal-title":"American Journal of Kidney Diseases"},{"key":"2026062922474327600_bib43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"American Journal of Kidney Diseases"},{"key":"2026062922474327600_bib44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5414\/CN109650","article-title":"Serum bone markers in ROD patients across the spectrum of decreases in GFR: activin A increases before all other markers","volume":"91","author":"Lima","year":"2019","journal-title":"Clin Nephrol"},{"key":"2026062922474327600_bib45","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10353","article-title":"A microRNA approach to discriminate cortical low bone turnover in renal osteodystrophy","volume":"4","author":"Nickolas","year":"2020","journal-title":"JBMR Plus"},{"key":"2026062922474327600_bib46","doi-asserted-by":"publisher","first-page":"e2903","DOI":"10.1210\/clinem\/dgaa317","article-title":"Biomarkers of bone turnover identify subsets of chronic kidney disease patients at higher risk for fracture","volume":"105","author":"Hughes-Austin","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062922474327600_bib47","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.kint.2020.12.024","article-title":"Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease","volume":"99","author":"Ursem","year":"2021","journal-title":"Kidney International"},{"key":"2026062922474327600_bib48","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/ki.2014.372","article-title":"Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease","volume":"87","author":"de\u00a0Oliveira","year":"2015","journal-title":"Kidney International"},{"key":"2026062922474327600_bib49","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00198-017-3956-9","article-title":"Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities","volume":"28","author":"Marques","year":"2017","journal-title":"Osteoporos Int"},{"key":"2026062922474327600_bib50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1365-2265.2011.04265.x","article-title":"Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism","volume":"76","author":"Lu","year":"2012","journal-title":"Clinical Endocrinology"},{"key":"2026062922474327600_bib51","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/ndt\/gfad043","article-title":"Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial","volume":"38","author":"Wang","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922474327600_bib52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s10157-017-1442-5","article-title":"Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism","volume":"22","author":"Shigematsu","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"2026062922474327600_bib53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00223-021-00910-8","article-title":"The role of bone volume, FGF23 and sclerostin in calcifications and mortality; a cohort study in CKD stage 5 patients","volume":"110","author":"Ferreira","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"2026062922474327600_bib54","doi-asserted-by":"publisher","first-page":"115604","DOI":"10.1016\/j.bone.2020.115604","article-title":"Regional variation in bone turnover at the iliac crest versus the greater trochanter","volume":"143","author":"Hughes-Austin","year":"2021","journal-title":"Bone"},{"key":"2026062922474327600_bib55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/ki.1990.187","article-title":"Renal bone disease 1990: an unmet challenge for the nephrologist","volume":"38","author":"Malluche","year":"1990","journal-title":"Kidney International"},{"key":"2026062922474327600_bib56","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","author":"Nickolas","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2026062922474327600_bib57","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s00198-019-05132-1","article-title":"Fracture-induced changes in biomarkers CTX, PINP, OC, and BAP\u2014a systematic review","volume":"30","author":"H\u00f8jsager","year":"2019","journal-title":"Osteoporos Int"},{"key":"2026062922474327600_bib58","doi-asserted-by":"publisher","first-page":"e4350","DOI":"10.1210\/clinem\/dgac522","article-title":"Lower bone turnover and skeletal PTH responsiveness in Japanese compared to European patients on hemodialysis","volume":"107","author":"Evenepoel","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062922474327600_bib59","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1210\/endrev\/bnac031","article-title":"Bone turnover markers: basic biology to clinical applications","volume":"44","author":"Schini","year":"2023","journal-title":"Endocr Rev"},{"key":"2026062922474327600_bib60","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00223-020-00786-0","article-title":"Traditional and non-traditional risk factors for osteoporosis in CKD","volume":"108","author":"J\u00f8rgensen","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"2026062922474327600_bib61","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1681\/ASN.2010121275","article-title":"Discriminants of prevalent fractures in chronic kidney disease","volume":"22","author":"Nickolas","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026062922474327600_bib62","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12882-017-0692-5","article-title":"Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study","volume":"18","author":"J\u00f8rgensen","year":"2017","journal-title":"BMC Nephrol"},{"key":"2026062922474327600_bib63","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11657-012-0110-3","article-title":"Risk factors for diminished bone mineral density among male hemodialysis patients\u2014a cross-sectional study","volume":"7","author":"Mirfakhraee","year":"2012","journal-title":"Arch Osteoporos"},{"key":"2026062922474327600_bib64","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2215\/CJN.09470913","article-title":"Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis","volume":"9","author":"Malluche","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026062922474327600_bib65","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1210\/clinem\/dgab623","article-title":"Interrelationships between sclerostin, secondary hyperparathyroidism, and bone metabolism in patients on hemodialysis","volume":"107","author":"Nakagawa","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062922474327600_bib66","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","article-title":"Risk factors for vertebral fractures in renal osteodystrophy","volume":"33","author":"Atsumi","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"key":"2026062922474327600_bib67","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2014a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"key":"2026062922474327600_bib68","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","article-title":"A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan","volume":"29","author":"Maruyama","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"key":"2026062922474327600_bib69","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ekir.2024.01.002","article-title":"Alkaline phosphatase and parathyroid hormone levels: international variation and associations with clinical outcomes in the DOPPS","volume":"9","author":"Yamamoto","year":"2024","journal-title":"Kidney International Reports\u00ae"},{"key":"2026062922474327600_bib70","doi-asserted-by":"publisher","first-page":"400","DOI":"10.34067\/KID.0000000656","article-title":"Higher serum alkaline phosphatase is a risk factor of death and fracture: a nationwide cohort study of Japanese patients on dialysis","volume":"6","author":"Maruyama","year":"2025","journal-title":"Kidney360"},{"key":"2026062922474327600_bib71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00223-013-9722-x","article-title":"High prevalence of vertebral fractures assessed by quantitative morphometry in hemodialysis patients, strongly associated with vascular calcifications","volume":"93","author":"Fusaro","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"2026062922474327600_bib72","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney International"},{"key":"2026062922474327600_bib73","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1681\/ASN.2021081081","article-title":"Natural history of bone disease following kidney transplantation","volume":"33","author":"J\u00f8rgensen","year":"2022","journal-title":"JASN"},{"key":"2026062922474327600_bib74","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2215\/CJN.0000000000000368","article-title":"Associations of changes in bone turnover markers with change in bone mineral density in kidney transplant patients","volume":"19","author":"J\u00f8rgensen","year":"2023","journal-title":"CJASN"},{"key":"2026062922474327600_bib75","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/toxins13070479","article-title":"Circulating p-cresyl sulfate, non-hepatic alkaline phosphatase and risk of bone fracture events in chronic kidney disease-mineral bone disease","volume":"13","author":"Chang","year":"2021","journal-title":"Toxins"},{"key":"2026062922474327600_bib76","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00774-019-01041-9","article-title":"Bone fracture risk factors in prevalent hemodialysis patients","volume":"38","author":"Matias","year":"2020","journal-title":"J Bone Miner Metab"},{"key":"2026062922474327600_bib77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0175936","article-title":"Human alkaline phosphatase dephosphorylates microbial products and is elevated in preterm neonates with a history of late-onset sepsis","volume":"12","author":"Pettengill","year":"2017","journal-title":"PLoS One"},{"key":"2026062922474327600_bib78","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2215\/CJN.0000000000000254","article-title":"Changes in bone quality after treatment with etelcalcetide","volume":"18","author":"Khairallah","year":"2023","journal-title":"CJASN"},{"key":"2026062922474327600_bib79","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/j.ajkd.2023.10.007","article-title":"Impact of parathyroidectomy versus oral cinacalcet on bone mineral density in patients on peritoneal dialysis with advanced secondary hyperparathyroidism: the PROCEED pilot randomized trial","volume":"83","author":"Wang","year":"2024","journal-title":"American Journal of Kidney Diseases"},{"key":"2026062922474327600_bib80","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/ASN.2014040414","article-title":"Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial","volume":"26","author":"Moe","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2026062922474327600_bib81","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00774-024-01500-y","article-title":"Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials","volume":"42","author":"Wakamatsu","year":"2024","journal-title":"J Bone Miner Metab"},{"key":"2026062922474327600_bib82","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026062922474327600_bib83","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s00268-017-4000-0","article-title":"The effect of parathyroidectomy on risk of hip fracture in secondary hyperparathyroidism","volume":"41","author":"Isaksson","year":"2017","journal-title":"World J Surg"},{"key":"2026062922474327600_bib84","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12882-020-01999-z","article-title":"Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies","volume":"21","author":"Cardoso","year":"2020","journal-title":"BMC Nephrol"},{"key":"2026062922474327600_bib85","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/ckj\/sfac230","article-title":"Management of fracture risk in CKD-traditional and novel approaches","volume":"16","author":"Haarhaus","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026062922474327600_bib86","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/ndt\/gfl567","article-title":"Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD)","volume":"22","author":"Fujii","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"key":"2026062922474327600_bib87","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1210\/jc.2014-1154","article-title":"An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis","volume":"99","author":"Chen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062922474327600_bib88","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00198-018-4688-1","article-title":"Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency","volume":"30","author":"Miyaoka","year":"2019","journal-title":"Osteoporos Int"},{"key":"2026062922474327600_bib89","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1038\/s41598-020-59143-8","article-title":"Denosumab for dialysis patients with osteoporosis: a cohort study","volume":"10","author":"Kunizawa","year":"2020","journal-title":"Sci Rep"},{"key":"2026062922474327600_bib90","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/ndt\/gfaa359","article-title":"Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational study","volume":"36","author":"Hiramatsu","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922474327600_bib91","doi-asserted-by":"publisher","first-page":"7781","DOI":"10.1038\/s41598-022-12029-3","article-title":"Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients","volume":"12","author":"Hori","year":"2022","journal-title":"Sci Rep"},{"key":"2026062922474327600_bib92","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s00774-022-01331-9","article-title":"The relationship between chronic kidney disease and denosumab-induced hypocalcemia in high-age osteoporotic patients","volume":"40","author":"Horikawa","year":"2022","journal-title":"J Bone Miner Metab"},{"key":"2026062922474327600_bib93","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s00198-018-4533-6","article-title":"Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies","volume":"29","author":"Thongprayoon","year":"2018","journal-title":"Osteoporos Int"},{"key":"2026062922474327600_bib94","doi-asserted-by":"publisher","first-page":"sfae048","DOI":"10.1093\/ckj\/sfae048","article-title":"Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?","volume":"17","author":"Lloret","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026062922474327600_bib95","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/jbmr.3676","article-title":"Effects of denosumab and alendronate on bone health and vascular function in hemodialysis patients: a randomized, controlled trial","volume":"34","author":"Iseri","year":"2019","journal-title":"J Bone Miner Res"},{"key":"2026062922474327600_bib96","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jama.2023.28239","article-title":"Severe hypocalcemia with denosumab among older female dialysis-dependent patients","volume":"331","author":"Bird","year":"2024","journal-title":"JAMA"},{"key":"2026062922474327600_bib97","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11255-020-02387-0","article-title":"Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients: review of an alkaline phosphatase-based treatment protocol","volume":"52","author":"Wong","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"2026062922474327600_bib98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6613659","article-title":"Risk factors for severe hypocalcemia in patients with secondary hyperparathyroidism after total parathyroidectomy","volume":"2021","author":"Wen","year":"2021","journal-title":"International Journal of Endocrinology"},{"key":"2026062922474327600_bib99","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jss.2020.05.036","article-title":"A nomogram to predict hungry bone syndrome after parathyroidectomy in patients with secondary hyperparathyroidism","volume":"255","author":"Wang","year":"2020","journal-title":"Journal of Surgical Research"},{"key":"2026062922474327600_bib100","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/0886022X.2021.2016445","article-title":"A single-center experience of parathyroidectomy in 1500 cases for secondary hyperparathyroidism: a retrospective study","volume":"44","author":"Zhao","year":"2022","journal-title":"Renal Failure"},{"key":"2026062922474327600_bib101","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3904\/kjim.2023.292","article-title":"Efficacy and safety of denosumab treatment for Korean patients with Stage 3b-4 chronic kidney disease and osteoporosis","volume":"39","author":"Kim","year":"2024","journal-title":"Korean J Intern Med"},{"key":"2026062922474327600_bib102","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00198-015-3377-6","article-title":"Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study","volume":"27","author":"Sumida","year":"2016","journal-title":"Osteoporos Int"},{"key":"2026062922474327600_bib103","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00223-022-01031-6","article-title":"One-year romosozumab treatment followed by one-year denosumab treatment for osteoporosis in patients on hemodialysis: an observational study","volume":"112","author":"Saito","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"2026062922474327600_bib104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2026062922474327600_bib105","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","article-title":"Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study","volume":"39","author":"Sato","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"2026062922474327600_bib106","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/1744-9987.12867","article-title":"Impact of weekly teriparatide on the bone and mineral metabolism in hemodialysis patients with relatively low serum parathyroid hormone: a pilot study","volume":"24","author":"Yamamoto","year":"2020","journal-title":"Ther Apher Dial"},{"key":"2026062922474327600_bib107","doi-asserted-by":"publisher","first-page":"219","DOI":"10.5414\/CN110993","article-title":"Treatment of bone loss in CKD5D: better survival in patients with non-high bone turnover","volume":"98","author":"Malluche","year":"2022","journal-title":"CN"},{"key":"2026062922474327600_bib108","doi-asserted-by":"publisher","first-page":"115157","DOI":"10.1016\/j.bone.2019.115157","article-title":"Denosumab failure associated with escape from suppression of bone resorption","volume":"131","author":"Jones","year":"2020","journal-title":"Bone"},{"key":"2026062922474327600_bib109","doi-asserted-by":"publisher","first-page":"e0113482","DOI":"10.1371\/journal.pone.0113482","article-title":"Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease","volume":"10","author":"Doyon","year":"2015","journal-title":"PLoS One"},{"key":"2026062922474327600_bib110","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/ndt\/gft275","article-title":"Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts","volume":"29","author":"Delanaye","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"key":"2026062922474327600_bib111","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1258\/acb.2012.011274","article-title":"Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase","volume":"49","author":"Fischer","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"2026062922474327600_bib112","doi-asserted-by":"publisher","first-page":"117487","DOI":"10.1016\/j.bone.2025.117487","article-title":"Reference values for cross-linked C-telopeptide of type 1 collagen and pro-collagen type1 N-terminal propeptide in children and adolescents: results from the Canadian Health Measures Survey","volume":"196","author":"Kim","year":"2025","journal-title":"Bone"},{"key":"2026062922474327600_bib113","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/17843286.2020.1769285","article-title":"Parathormone, bone alkaline phosphatase and 25-hydroxyvitamin D status in a large cohort of 1200 children and teenagers","volume":"77","author":"Ladang","year":"2022","journal-title":"Acta Clinica Belgica"},{"key":"2026062922474327600_bib114","doi-asserted-by":"publisher","first-page":"110582","DOI":"10.1016\/j.clinbiochem.2023.05.001","article-title":"Reference intervals for plasma beta-CTX and P1NP in children: a systematic review and pooled estimates","volume":"118","author":"Chubb","year":"2023","journal-title":"Clinical Biochemistry"},{"key":"2026062922474327600_bib115","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000058378","article-title":"A cross-sectional study on biochemical parameters of bone turnover and vitamin D metabolites in healthy Dutch children and young adults","volume":"57","author":"van\u00a0der\u00a0Sluis","year":"2002","journal-title":"Horm Res Paediatr"},{"key":"2026062922474327600_bib116","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/biomedicines13010034","article-title":"Reference intervals (RIs) of the bone turnover markers (BTMs) in children and adolescents: a proposal for effective use","volume":"13","author":"Brescia","year":"2024","journal-title":"Biomedicines"},{"key":"2026062922474327600_bib117","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1007\/s00467-022-05825-6","article-title":"Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce","volume":"38","author":"Bacchetta","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"2026062922474327600_bib118","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ndt\/gfaa210","article-title":"Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA","volume":"36","author":"Bakkaloglu","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922474327600_bib119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","journal-title":"Kidney International Supplements"},{"key":"2026062922474327600_bib120","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4\u2013G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922474327600_bib121","doi-asserted-by":"publisher","first-page":"e2544","DOI":"10.1210\/clinem\/dgae842","article-title":"Estimating net bone formation relative to resorption using reference bone turnover markers","volume":"110","author":"Shieh","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062922474327600_bib122","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000524961","article-title":"Bone turnover, mineralization, and volume estimated by 18F-sodium fluoride PET\/CT and biomarkers in chronic kidney disease: mineral and bone disorder compared with bone biopsy","volume":"53","author":"Vrist","year":"2022","journal-title":"Am J Nephrol"},{"key":"2026062922474327600_bib123","doi-asserted-by":"publisher","first-page":"115267","DOI":"10.1016\/j.bone.2020.115267","article-title":"Correlation between (18)F-sodium fluoride positron emission tomography and bone histomorphometry in dialysis patients","volume":"134","author":"Aaltonen","year":"2020","journal-title":"Bone"},{"key":"2026062922474327600_bib124","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1210\/jcem.77.4.8408470","article-title":"Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry","volume":"77","author":"Messa","year":"1993","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"2026062922474327600_bib125","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12149-024-01929-1","article-title":"Assessment of regional and total skeletal metabolism using (18)F-NaF PET\/CT in patients with chronic kidney disease","volume":"38","author":"Usmani","year":"2024","journal-title":"Ann Nucl Med"},{"key":"2026062922474327600_bib126","doi-asserted-by":"publisher","first-page":"12536","DOI":"10.1038\/s41598-024-63476-z","article-title":"Bone turnover prediction in patients with chronic kidney disease (CKD) undergoing hemodialysis using shortened dynamic (18)F-NaF PET\/CT K(i)-Patlak","volume":"14","author":"Sanoesan","year":"2024","journal-title":"Sci Rep"},{"key":"2026062922474327600_bib127","doi-asserted-by":"publisher","first-page":"100200","DOI":"10.1016\/j.bonr.2019.100200","article-title":"Calcium isotope ratios in blood and urine: a new biomarker for the diagnosis of osteoporosis","volume":"10","author":"Eisenhauer","year":"2019","journal-title":"Bone Reports"},{"key":"2026062922474327600_bib128","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1210\/jcem-67-4-741","article-title":"Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers","volume":"67","author":"Eastell","year":"1988","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"2026062922474327600_bib129","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jbmr.4158","article-title":"Naturally occurring stable calcium isotope ratios in body compartments provide a novel biomarker of bone mineral balance in children and young adults","volume":"36","author":"Shroff","year":"2021","journal-title":"J Bone Miner Res"},{"key":"2026062922474327600_bib130","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.kint.2022.04.024","article-title":"Naturally occurring stable calcium isotope ratios are a novel biomarker of bone calcium balance in chronic kidney disease","volume":"102","author":"Shroff","year":"2022","journal-title":"Kidney International"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag033\/66957992\/gfag033.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/7\/1357\/66957992\/gfag033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/7\/1357\/66957992\/gfag033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:47:49Z","timestamp":1782787669000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/7\/1357\/8488598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":130,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,17]]},"published-print":{"date-parts":[[2026,6,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag033","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,2,17]]}}}